Gene · 116085
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating Metabolomics and Network Pharmacology to Explore the Active Compounds and Mechanism of Fructus Gardenia in Hyperuricemia. | J Food Sci | 2026 | 41485197 | PubTator, text mining | PubMed |
| Molecular Determinants of Selective and High-affinity Binding of the Scaffold Protein PDZK1 to the Urate Transporter URAT1. | J Mol Biol | 2026 | 41453723 | PubTator, text mining | PubMed |
| Solute carrier inhibitors in kidney disease therapy: mechanisms and clinical implications. | Diabetes Res Clin Pract | 2026 | 41443301 | PubTator, text mining | PubMed |
| Serum urate, cardiovascular mediators, and atrial fibrillation: genetic evidence for URAT1-targeted therapy. | Clin Rheumatol | 2026 | 41369868 | PubTator, text mining | PubMed |
| Benzoheterocyclic analogues of dotinurad as orally efficacious human urate transporter 1 inhibitors: Design, synthesis, structure-activity relationships, and pharmacokinetic studies. | Eur J Med Chem | 2026 | 41353866 | PubTator, text mining | PubMed |
| Febuxostat alleviates gout-associated hyperuricemia and inflammation by downregulating IL1A to modulate TLR2/TLR4/NF-κB signaling pathway. | Int Immunopharmacol | 2026 | 41330172 | PubTator, text mining | PubMed |
| Fucoidan/chitosan coated nanoliposomes enhancing URAT1 targeting of rutin for alleviating hyperuricemia. | Int J Biol Macromol | 2026 | 41297333 | PubTator, text mining | PubMed |
| Comment on "The effects of GLUT9 and URAT1 inhibitors on cardiovascular diseases: a drug-targeted Mendelian randomization study". | Int Urol Nephrol | 2026 | 41191269 | PubTator, text mining | PubMed |
| Renal Nicotinate Handling by Urate Transporter 1: Hidden Benefits of Urate Transporter 1-Targetting Uricosuric Agents. | Kidney360 | 2026 | 41148214 | PubTator, text mining | PubMed |
| Role of urate transporters in the kidneys and intestine in uric acid homeostasis. | Kidney Res Clin Pract | 2026 | 40528479 | PubTator, text mining | PubMed |
| Gitelman Syndrome in the Sixth Decade: An Atypical Presentation with Severe Electrolyte Abnormalities and Genetic Heterogeneity. | Ann Afr Med | 2026 | 40452344 | PubTator, text mining | PubMed |
| Evolutionary, genetic, and mechanistic insights into uric acid regulation and sex differences. | Kidney Res Clin Pract | 2025 | 42298985 | PubTator, text mining | PubMed |
| The hypouricemic effect and mechanism of tuna (Thunnus albacares) peptide and screening its functional peptide segments. | Food Res Int | 2025 | 41606926 | PubTator, text mining | PubMed |
| Genome-wide association studies and traditional Chinese medicine in hyperuricemia: current evidence and mechanistic insights. | Front Pharmacol | 2025 | 41601955 | PubTator, text mining | PubMed |
| Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors for Uricosuria. | Electrolyte Blood Press | 2025 | 41541562 | PubTator, text mining | PubMed |
| In vivo and in vitro experimental models for urolithiasis pathophysiology research. | Asian J Urol | 2025 | 41467193 | PubTator, text mining | PubMed |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects. | Drug Des Devel Ther | 2025 | 41340907 | PubTator, text mining | PubMed |
| Intracellular Calcium Dysregulation: The Hidden Culprit in the Diabetes-Gout Nexus. | Biomedicines | 2025 | 41301787 | PubTator, text mining | PubMed |
| Comprehensive gene heritability estimation reveals the genetic architecture of rare coding variants underlying complex traits. | bioRxiv | 2025 | 41278985 | PubTator, text mining | PubMed |
| Lactiplantibacillus plantarum WLPL04 from Human Breast Milk Attenuates Hyperuricemia via Coordinated Purine Salvage Pathway, Renal Transporter Regulation, and Gut Microbiota Remodeling. | Nutrients | 2025 | 41228519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116085/papers?page=3